EGFR and head and neck squamous cell carcinoma: Recently Lattanzio et al. reported that elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high EGFR expression predicted favorable outcome in patients with LA-HNSCC treated with cetuximab and RT [22].